SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-026392
Filing Date
2024-08-13
Accepted
2024-08-13 16:15:54
Documents
56
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dyai20240630_10q.htm   iXBRL 10-Q 1097710
2 EXHIBIT 31.1 ex_678862.htm EX-31.1 9530
3 EXHIBIT 31.2 ex_678863.htm EX-31.2 9402
4 EXHIBIT 32.1 ex_678864.htm EX-32.1 3803
5 EXHIBIT 32.2 ex_678865.htm EX-32.2 3791
11 logo.jpg GRAPHIC 8775
  Complete submission text file 0001437749-24-026392.txt   6213049

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dyai-20240630.xsd EX-101.SCH 47491
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dyai-20240630_cal.xml EX-101.CAL 36984
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20240630_def.xml EX-101.DEF 374753
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20240630_lab.xml EX-101.LAB 334236
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20240630_pre.xml EX-101.PRE 400541
59 EXTRACTED XBRL INSTANCE DOCUMENT dyai20240630_10q_htm.xml XML 1067147
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

IRS No.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32513 | Film No.: 241201693
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)